CMIDX
Price
$21.09
Change
+$0.17 (+0.81%)
Updated
Jun 2 closing price
Net Assets
389.12M
RPMGX
Price
$99.36
Change
-$0.22 (-0.22%)
Updated
Jun 2 closing price
Net Assets
23.23B
Interact to see
Advertisement

CMIDX vs RPMGX

Header iconCMIDX vs RPMGX Comparison
Open Charts CMIDX vs RPMGXBanner chart's image
CMIDX vs RPMGX Comparison Chart in %
View a ticker or compare two or three
VS
CMIDX vs. RPMGX commentary
Jun 04, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CMIDX is a StrongBuy and RPMGX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RPMGX has more cash in the bank: 23.2B vs. CMIDX (389M). CMIDX (0.00) and RPMGX (0.00) have matching dividends . CMIDX was incepted earlier than RPMGX: CMIDX (14 years) vs RPMGX (34 years). CMIDX (1.08) is less costly to investors than RPMGX (0.77). CMIDX is a more actively managed with annual turnover of: 57.00 vs. RPMGX (31.50). CMIDX has a lower initial minimum investment than RPMGX: CMIDX (2000) vs RPMGX (2500). RPMGX annual gain was more profitable for investors over the last year : 2.62 vs. CMIDX (0.24). RPMGX return over 5 years is better than : -16.15 vs. CMIDX (-31.83).
CMIDXRPMGXCMIDX / RPMGX
Total Expense Ratio1.080.77140%
Annual Report Gross Expense Ratio1.080.77140%
Fund Existence14 years34 years-
Gain YTD14.3792.406598%
Front LoadN/AN/A-
Min. Initial Investment2000250080%
Min. Initial Investment IRAN/AN/A-
Net Assets389M23.2B2%
Annual Yield % from dividends0.000.00-
Returns for 1 year0.242.629%
Returns for 3 years-10.484.00-262%
Returns for 5 years-31.83-16.15197%
Returns for 10 years35.4232.51109%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
OGEN0.61N/A
+0.83%
Oragenics
TRU73.750.24
+0.33%
TransUnion
ETD20.44-0.20
-0.97%
Ethan Allen Interiors
SUPN44.07-0.69
-1.54%
Supernus Pharmaceuticals
IBIO1.76-0.13
-6.88%
iBio